MBX
MBX Biosciences Inc.
$31.75
-$0.10(-0.31%)
45
Overall
60
Value
41
Tech
34
Quality
Market Cap
$34.31M
Volume
247.66K
52W Range
$9.43 - $45.85
Target Price
$69.09
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $26.1M | $35.3M | $68.2M | $98.1M | ||
| Research & Development | $21.4M | $28.5M | $57.4M | $79.2M | ||
| Research Expense | $21.4M | $28.5M | $57.4M | $79.2M | ||
| Selling, General & Administrative | $3.8M | $6.8M | $10.8M | $18.9M | ||
| General & Administrative Expenses | $3.8M | $6.8M | $10.8M | $18.9M | ||
| Other Operating Expenses | $899.0K | -- | -- | -- | ||
| OPERATING INCOME | ||||||
| Operating income | $-26.1M | $-35.3M | $-68.2M | $-98.1M | ||
| EBITDA | $-25.7M | $-32.4M | $-61.7M | $-86.7M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $374.0K | -- | -- | -- | ||
| Intinc | $372.0K | $2.7M | $6.3M | $11.1M | ||
| Net Non-Operating Interest Income/Expense | $-2.0K | $2.7M | $6.3M | $11.1M | ||
| Other Income/Expense | $73.0K | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-25.8M | $-32.6M | $-61.9M | $-87.0M | ||
| Pre-Tax Income | $-26.1M | $-32.6M | $-61.9M | $-87.0M | ||
| NET INCOME | ||||||
| Net Income | $-26.1M | $-32.6M | $-61.9M | $-87.0M | ||
| Net Income (Continuing Operations) | $-26.1M | $-32.6M | $-61.9M | $-87.0M | ||
| Net Income (Discontinued Operations) | $-26.1M | $-32.6M | $-61.9M | $-87.0M | ||
| Net Income (Common Stockholders) | $-26.1M | $-32.6M | $-61.9M | $-87.0M | ||
| Normalized Income | $-19.2M | $-23.9M | $-61.3M | $-86.1M | ||
| TOTALS | ||||||
| Total Expenses | $26.1M | $35.3M | $68.2M | $98.1M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $667.0K | $1.0M | $10.6M | $36.5M | ||
| Average Shares Outstanding (Diluted) | $667.0K | $1.0M | $10.6M | $36.5M | ||
| Shares Outstanding | $47.6M | $47.6M | $47.6M | $47.5M | ||
| Basic EPS | $-39.18 | $-31.96 | $-5.82 | $-2.38 | ||
| Basic EPS (Continuing Operations) | $-39.18 | $-31.96 | $-5.82 | $-2.38 | ||
| Diluted EPS | $-39.18 | $-31.96 | $-5.82 | $-2.38 | ||
| Diluted EPS (Continuing Operations) | $-39.18 | $-31.96 | $-5.82 | $-2.38 | ||
| OTHER METRICS | ||||||
| Other Gand A | $3.8M | $6.8M | $10.8M | $18.9M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MBX | $31.75 | -0.3% | 247.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |